Skip to main content

Advertisement

Log in

Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-β1-Smad2 dependent pathway

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

An Erratum to this article was published on 01 June 2010

Abstract

Objective

To assess the effects of propofol treatments at different time points on acute lung injury and on the expression of transforming growth factor (TGF)-β1 and the downstream target of TGF-β1, Smad 2, in the lung tissues in the endotoxic rats.

Methods

Seventy-six Wistar rats were randomly assigned to five groups: control group (saline only), endotoxemic group [lipopolysaccharide (LPS) 8 mg kg−1, i.v.], and three propofol-treated groups. For the propofol-treated groups, propofol (5 mg kg−1, i.v. bolus) was administered either 1 h before LPS, simultaneously with LPS, and 1 h after LPS, and all were followed by infusion of 10 mg kg−1 h−1 of propofol for 5 h after LPS. Lung tissues were sampled to measure myeloperoxidase activity and expression of TGF-β1 and Smad2 and to assess pulmonary microvascular permeability and histopathological changes.

Results

The hemodynamics, arterial blood gases, 5 h survival rate, pulmonary microvascular permeability, and acute lung injury scores were significantly better, and expression of TGF-β1 and Smad2 and myeloperoxidase activity in lung tissues was significantly lower in the pretreatment and simultaneous treatment groups compared to the endotoxemic group. However, there were no significant differences in all observed variables between the endotoxemic and postreatment groups. Except for TGF-β1 expression in lung tissues, the other observed variables were also not significantly different between the pretreatment and simultaneous treatment groups.

Conclusions

In the endotoxic rat model, pretreatment and simultaneous treatment with propofol provided protection against acute lung injury by inhibiting the TGF-β1-Smad2 dependent pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–9.

    Article  CAS  PubMed  Google Scholar 

  2. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med. 1999;27:304–12.

    Article  CAS  PubMed  Google Scholar 

  3. Wesselkamper SC, Case LM, Henning LN, Borchers MT, Tichelaar JW, Mason JM, et al. Gene expression changes during the development of acute lung injury: role of transforming growth factor-β. Am J Respir Crit Care Med. 2005;172:1399–411.

    Article  PubMed  Google Scholar 

  4. Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD. The acute respiratory distress syndrome: a role for transforming growth factor-ß1. Am J Respir Cell Mol Biol. 2003;28:499–503.

    Article  CAS  PubMed  Google Scholar 

  5. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1ß induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107:1529–36.

    Article  CAS  PubMed  Google Scholar 

  6. Birukova AA, Birukov KG, Adyshev D, Usatyuk P, Natarajan V, Garcia JG, et al. Involvement of microtubules and Rho pathway in TGF-ß-induced lung vascular barrier dysfunction. J Cell Physiol. 2005;204:934–7.

    Article  CAS  PubMed  Google Scholar 

  7. Clements RT, Minnear FL, Singer HA, Keller RS, Vincent PA. RhoA and Rhokinase dependent and independent signals mediate TGF-ß-induced pulmonary endothelial cytoskeletal reorganization and permeability. Am J Physiol Lung Cell Mol Physiol. 2005;288:L294–306.

    Article  CAS  PubMed  Google Scholar 

  8. Shenkar R, Coulson WF, Abraham E. Anti- TGF-β1 monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Respir Cell Mol Biol. 1994;11:351–7.

    CAS  PubMed  Google Scholar 

  9. Marik PE, Zaloga GP. Therapeutic sedation: has its time come? Crit Care Med. 2002;30:949–52.

    Article  PubMed  Google Scholar 

  10. Young C, Knudsen N, Andrew H. Sedation in the intensive care unit. Crit Care Med. 2000;28:854–66.

    Article  CAS  PubMed  Google Scholar 

  11. Kwak SH, Choi JI, Park JT. Effects of propofol on endotoxin-induced acute lung injury in rabbit. J Korean Med Sci. 2004;19:55–61.

    Article  CAS  PubMed  Google Scholar 

  12. Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann NY Acad Sci. 2005;1042:262–71.

    Article  CAS  PubMed  Google Scholar 

  13. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med. 2002;30:904–7.

    Article  CAS  PubMed  Google Scholar 

  14. Gao J, Zhao WX, Zhou LJ, Zeng BX, Yao SL, Liu D, et al. Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction. Inflamm Res. 2006;55:385–92.

    Article  CAS  PubMed  Google Scholar 

  15. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg. 2005;100:810–6.

    Article  CAS  PubMed  Google Scholar 

  16. Groeneveld ABJ. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vasc Pharm. 2003;39:247–56.

    Article  CAS  Google Scholar 

  17. Ware LB, Matthay MB. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–49.

    Article  CAS  PubMed  Google Scholar 

  18. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, et al. TGF-ß is a critical mediator of acute lung injury. J Clin Invest. 2001;107:1537–44.

    Article  CAS  PubMed  Google Scholar 

  19. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-ß responses. Cell. 1998;95:737–40.

    Article  CAS  PubMed  Google Scholar 

  20. Lu Q, Harrington EO, Jackson H, Morin N, Shannon C, Rounds S. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves SMAD2-dependent p38 activation and subsequent RhoA activation. J Appl Physiol. 2006;101:375–84.

    Article  CAS  PubMed  Google Scholar 

  21. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem. 2001;276:15362–8.

    Article  CAS  PubMed  Google Scholar 

  22. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol. 1994;129:163–9.

    Article  CAS  PubMed  Google Scholar 

  23. Heller A, Heller S, Blecken S, Urbaschek R, Koch T. Effects of intravenous anesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand. 1998;425:518–26.

    Article  Google Scholar 

  24. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med. 2000;28:1101–6.

    Article  CAS  PubMed  Google Scholar 

  25. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol. 1998;161:440–7.

    CAS  PubMed  Google Scholar 

  26. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med. 1996;24:584–9.

    Article  CAS  PubMed  Google Scholar 

  27. Hubsch AP, Powell FS, Lerch PG, Doran JE. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ Shock. 1993;40:14–23.

    CAS  PubMed  Google Scholar 

  28. Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology. 2005;103:860–76.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported in part by a grant from the Natural Science Foundation of Guangdong Province (2005-259). Other funds come from departmental sources.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ju Gao.

Additional information

Responsible Editor: M. Katori.

J. Gao and F.-S. Xue contributed equally to the writing of the article.

An erratum to this article can be found at http://dx.doi.org/10.1007/s00011-010-0218-0

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, J., Zhao, WX., Xue, FS. et al. Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-β1-Smad2 dependent pathway. Inflamm. Res. 59, 491–500 (2010). https://doi.org/10.1007/s00011-009-0110-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-009-0110-y

Keywords

Navigation